Shares in Aldeyra Therapeutics Inc (ALDX) exploded 30% in after-hours trading on Tuesday, following news that the company will host a conference call …
Ritu Baral sees 35% upside for Aldeyra on back of positive Phase 2a dry eye study.
A glimpse into three biotech movers: ALDX, SAGE, AEMD.
